HDAC3 and hepatocellular carcinoma: In addition, HCC patients with higher HDAC3 expression had worse overall survival rate (P<0.05, Figure 2C) and recurrence-free survival rate (P<0.05, Figure 2D), which were consistent with the data from Kaplan-Meier Plotter (P<0.05, Supplementary Figure 3B).